RTX-CBS

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRTX-CBS
Drug Alias Namecystathionine beta-synthase expressing red blood cells (Rubius Therapeutics)RTX-CBS
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapy
Mechanisms of ActionCystathionine beta-synthase modulators
TargetsCystathionine beta-synthase
Therapy Area/IndicationsHomocystinuria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRubius Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRubius Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHomocystinuria

Other Information

ATC CodeN/A
Related LinksN/A